GALAZOLIN NASAL DROPS 0.05% VIAL 10ML
GALAZOLIN NASAL DROPS 0.05% VIAL 10ML
Security policy (edit with Customer reassurance module)
Delivery policy (edit with Customer reassurance module)
Return policy (edit with Customer reassurance module)
Mechanism of actionVasoconstrictor drug for local use in ENT practice. When using the drug in the recommended doses, xylometazoline is practically not subjected to systemic absorption, in connection with this, there are no data on the pharmacokinetics of Galazolin. Indications and usage- acute rhinitis (viral, bacterial, allergic); Galazolin in the form of drops and gel 0.05% prescribed children aged 2 to 6 years 1-2 drops in each nostril 1-2 times / day. Adverse reactionsLocal reactions: sometimes - burning, dryness of the nasal mucosa, sneezing; rarely, reactive hyperemia (a strongly pronounced feeling of nasal congestion after the effect of the drug is used). Contraindications- increased intraocular pressure; Pregnancy and breastfeedingThe drug should be used only after assessing the risk / benefit ratio for the fetus and mother. Special notesProlonged use of the drug leads to a weakening of its action, the development of atrophy of the nasal mucosa and reactive hyperemia with rhinitis medication. OverdosageSymptoms: in case of accidental ingestion of the drug (more often in children), tachycardia, arrhythmia, increased blood pressure, confusion are noted. Drug InteractionsWith simultaneous use of xylometazoline (overdose or accidental ingestion) with tricyclic antidepressants or MAO inhibitors (including prior to the use of xylometazoline) an increase in blood pressure is noted. Storage conditionsThe drug should be stored in a dark place at a temperature of 15 ° to 25 ° C, out of reach of children. Shelf life - 4 years. |